Cargando…
Incidence and Outcomes of CNS Tumors in Chinese Children: Comparative Analysis With the Surveillance, Epidemiology, and End Results Program
PURPOSE: Despite being the most common pediatric solid tumors, incidence and outcome of CNS tumors in Chinese children have not been systematically reported. We addressed this knowledge gap by comparing the epidemiology of pediatric CNS tumors in Hong Kong and the United States. PATIENTS AND METHODS...
Autores principales: | Liu, Anthony P. Y., Liu, Qi, Shing, Matthew M. K., Ku, Dennis T. L., Fu, Eric, Luk, Chung-Wing, Ling, Siu-Cheung, Cheng, Kevin K. F., Kwong, Dora L. W., Ho, Wilson W. S., Ng, Ho-Keung, Gajjar, Amar, Yasui, Yutaka, Chan, Godfrey C. F., Armstrong, Gregory T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268901/ https://www.ncbi.nlm.nih.gov/pubmed/32392090 http://dx.doi.org/10.1200/JGO.19.00378 |
Ejemplares similares
-
OMIC-07. FEASIBILITY AND UTILITY OF EPIGENOMIC PROFILING FOR CHILDHOOD CNS TUMORS IN HONG KONG
por: P.Y. Liu, Anthony, et al.
Publicado: (2021) -
GERM-03. CLINICAL FEATURES AND OUTCOME OF CHILDREN WITH INTRACRANIAL NON-GERMINOMATOUS GERM CELL TUMORS: A POPULATION-BASED STUDY IN HONG KONG
por: P.Y. Liu, Anthony, et al.
Publicado: (2021) -
LGG-17. CLINICAL OUTCOME OF PEDIATRIC LOW GRADE GLIOMA WITH POSITIVE BRAF-FUSION TREATED WITH MEK INHIBITOR
por: Dennis, T L Ku, et al.
Publicado: (2021) -
HGG-48. ROS1 INHIBITOR ENTRECTINIB USE IN RELAPSE/REFRACTORY INFANTILE GLIOBLASTOMA WITH POSITIVE ROS1 FUSION - A CASE REPORT WITH PROMISING RESPONSE
por: Ku, Dennis Tak-Loi, et al.
Publicado: (2020) -
Genome-Wide DNA Methylation Profiling as Frontline Diagnostics for Central Nervous System Embryonal Tumors in Hong Kong
por: Tam, Otto C. H., et al.
Publicado: (2023)